Wingate Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454K Buy
1,788
+1
+0.1% +$233 0.2% 79
2026
Q1
$437K Buy
1,787
+1
+0.1% +$233 0.23% 75
2025
Q4
$370K Sell
1,786
-198
-10% -$39.2K 0.21% 83
2025
Q3
$368K Buy
1,984
+156
+9% +$26.7K 0.25% 76
2025
Q2
$279K Buy
1,828
+216
+13% +$33.2K 0.25% 84
2025
Q1
$267K Hold
1,612
0.31% 79
2024
Q4
$233K Buy
+1,612
New +$250K 0.23% 88

Other funds holding JNJ

Wingate Wealth Advisors's JNJ Position: Q2 2026 in Review

Wingate Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 0.06% in Q2 2026, buying an estimated $233 and bringing the position to 1,788 shares worth $454K. The position accounts for 0.2% of the portfolio, ranked #79.

Wingate Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wingate Wealth Advisors held 1,788 shares of Johnson & Johnson worth $454K as of Q2 2026.
  • Wingate Wealth Advisors bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.2% of Wingate Wealth Advisors's portfolio in Q2 2026, its #79 holding.
  • Wingate Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wingate Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.